These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21130261)

  • 1. Re: Guzzo et al.: Prediction of mortality after radical prostatectomy by Charlson comorbidity index. (Urology 2010;76:553-557).
    Froehner M; Koch R; Litz RJ; Wirth MP
    Urology; 2010 Dec; 76(6):1522; author reply 1522. PubMed ID: 21130261
    [No Abstract]   [Full Text] [Related]  

  • 2. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
    Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
    J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Guzzo TJ, Vira MA, Neway W, et al: Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology 69: 1147-1151, 2007.
    Guzzo TJ; Vira MA; Dey W; Hwang WT; Tomaszewski J; VanArsdalen K; Wein AJ; Malkowicz B
    Urology; 2008 Jun; 71(6):1230-1. PubMed ID: 18400267
    [No Abstract]   [Full Text] [Related]  

  • 4. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
    Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Haase M; Klenk U; Oehlschlaeger S; Baretton GB; Wirth MP
    Scand J Urol Nephrol; 2005; 39(6):449-54. PubMed ID: 16303719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
    Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Dorey FJ; Walsh PC; Partin AW
    J Clin Oncol; 2007 May; 25(13):1765-71. PubMed ID: 17470867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
    Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
    J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
    Walz J; Montorsi F; Jeldres C; Suardi N; Shariat SF; Perrotte P; Arjane P; Graefen M; Pharand D; Karakiewicz PI
    BJU Int; 2008 Apr; 101(7):826-32. PubMed ID: 18321316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
    Russo A; Autelitano M; Bisanti L
    J Natl Cancer Inst; 2006 Mar; 98(6):421; author reply 421-2. PubMed ID: 16537836
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Tollefson et al.: Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy (Urology 2011;77:1161-1165).
    Schwartz GG; Skinner HG
    Urology; 2011 Jun; 77(6):1511-2; author reply 1512. PubMed ID: 21624612
    [No Abstract]   [Full Text] [Related]  

  • 12. [A retrospective comparison of radical retropubic prostatectomy and of iodine-125 brachytherapy in localized prostatic carcinoma].
    Kovács G
    Strahlenther Onkol; 2000 Mar; 176(3):150. PubMed ID: 10742837
    [No Abstract]   [Full Text] [Related]  

  • 13. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Aurélien Descazeaud, Marc Zerbib, Thierry Flam et al. Can pT0 stage of prostate cancer be predicted before radical prostatectomy? Eur Urol 2006;50:1248-53.
    Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L
    Eur Urol; 2007 Jul; 52(1):294-5. PubMed ID: 17383812
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of care for radical prostatectomy in the United States from 2003 to 2005.
    Hu JC; Hevelone ND; Ferreira MD; Lipsitz SR; Choueiri TK; Sanda MG; Earle CC
    J Urol; 2008 Nov; 180(5):1969-74. PubMed ID: 18801512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: White et al.: Comparative analysis of surgical margins between radical retropubic prostatectomy and RALP: Are patients sacrificed during initiation of robotic program? (Urology 2009;73:567-571).
    Otto T; Gerullis H; Theuerkauf I
    Urology; 2009 Aug; 74(2):475-6; author reply 476. PubMed ID: 19646635
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
    Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
    Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
    Urology; 2006 Sep; 68(3):583-6. PubMed ID: 16979740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Hakenberg OW; Wirth MP
    Eur Urol; 2005 Feb; 47(2):190-5; discussion 195. PubMed ID: 15661413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.